HUP0003629A2 - Szinergista gyógyszerkészítmény diabetes kezelésére amely dioxo-tiazolidint, inzulin secretagogot és diguanidint tartalmaz - Google Patents

Szinergista gyógyszerkészítmény diabetes kezelésére amely dioxo-tiazolidint, inzulin secretagogot és diguanidint tartalmaz

Info

Publication number
HUP0003629A2
HUP0003629A2 HU0003629A HUP0003629A HUP0003629A2 HU P0003629 A2 HUP0003629 A2 HU P0003629A2 HU 0003629 A HU0003629 A HU 0003629A HU P0003629 A HUP0003629 A HU P0003629A HU P0003629 A2 HUP0003629 A2 HU P0003629A2
Authority
HU
Hungary
Prior art keywords
treatment
diguanide
pharmaceutical composition
insulin secretagogue
diabetes containing
Prior art date
Application number
HU0003629A
Other languages
English (en)
Inventor
Robin Edwin Buckingham
Stephen Alistair Smith
Original Assignee
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.
Publication of HUP0003629A2 publication Critical patent/HUP0003629A2/hu
Publication of HUP0003629A3 publication Critical patent/HUP0003629A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

A találmány diabetes mellitus, különösen II. típusú diabetes, valamintdiabetes mellitusszal kapcsolatos állapotok emlősökben végzettkezelési eljárására vonatkozik, amelynek során egy ilyen kezeléstigénylő emlősnek beadják egy inzulin szenzibilizátor, egy inzulinsecretagogum és egy biguanidin anti-hyperglykaemiás hatóanyag hatásos,nemtoxikus és gyógyászatilag elfogadható mennyiségét. A találmánykiterjed az említett hatóanyagokat tartalmazó gyógyszerkészítményekreis. Ó
HU0003629A 1997-07-18 1998-07-16 Synergic pharmaceutical composition for the treatment of diabetes containing thiazolidinedione, insulin secretagogue and diguanide HUP0003629A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9715295A GB9715295D0 (en) 1997-07-18 1997-07-18 Novel method of treatment
PCT/GB1998/002110 WO1999003477A1 (en) 1997-07-18 1998-07-16 Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide

Publications (2)

Publication Number Publication Date
HUP0003629A2 true HUP0003629A2 (hu) 2001-07-30
HUP0003629A3 HUP0003629A3 (en) 2003-04-28

Family

ID=10816167

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0003629A HUP0003629A3 (en) 1997-07-18 1998-07-16 Synergic pharmaceutical composition for the treatment of diabetes containing thiazolidinedione, insulin secretagogue and diguanide

Country Status (40)

Country Link
EP (1) EP1001783B1 (hu)
JP (2) JP2001510159A (hu)
KR (1) KR100671918B1 (hu)
CN (1) CN1264303A (hu)
AP (1) AP1352A (hu)
AR (1) AR016349A1 (hu)
AT (1) ATE305790T1 (hu)
AU (1) AU8448898A (hu)
BG (1) BG64785B1 (hu)
BR (1) BR9810445A (hu)
CA (1) CA2296653C (hu)
CO (1) CO4940420A1 (hu)
CY (1) CY1105254T1 (hu)
DE (1) DE69831808T2 (hu)
DK (1) DK1001783T3 (hu)
DZ (1) DZ2562A1 (hu)
EA (1) EA003021B1 (hu)
ES (1) ES2251093T3 (hu)
GB (1) GB9715295D0 (hu)
HK (1) HK1028550A1 (hu)
HU (1) HUP0003629A3 (hu)
ID (1) ID24211A (hu)
IL (1) IL134046A0 (hu)
IN (1) IN189275B (hu)
MA (1) MA24607A1 (hu)
MY (1) MY155219A (hu)
NO (1) NO325727B1 (hu)
NZ (2) NZ501164A (hu)
OA (1) OA11279A (hu)
PE (1) PE99599A1 (hu)
PL (2) PL198017B1 (hu)
SA (1) SA98190468B1 (hu)
SI (1) SI1001783T1 (hu)
SK (1) SK285484B6 (hu)
TR (1) TR200000134T2 (hu)
TW (1) TW505516B (hu)
UA (1) UA70303C2 (hu)
UY (1) UY25102A1 (hu)
WO (1) WO1999003477A1 (hu)
ZA (1) ZA986363B (hu)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6011049A (en) * 1997-02-19 2000-01-04 Warner-Lambert Company Combinations for diabetes
US6099862A (en) * 1998-08-31 2000-08-08 Andrx Corporation Oral dosage form for the controlled release of a biguanide and sulfonylurea
SK287038B6 (sk) * 1998-11-12 2009-10-07 Smithkline Beecham Plc Farmaceutický prostriedok na postupné uvoľňovanie 5-[4-[2-(N- metyl-N-(2-pyridyl)amino)etoxy]benzyl]tiazolidín-2,4-diónu a metformínu a spôsob jeho výroby
SE9902918D0 (sv) * 1999-08-13 1999-08-13 Pharmacia & Upjohn Ab Methods for identification of compounds stimulating insulin secretion
JP2003514011A (ja) * 1999-11-16 2003-04-15 スミスクライン ビーチャム パブリック リミテッド カンパニー チアゾリジンジオン−塩酸メトホルミンを含む医薬組成物
MY125516A (en) * 1999-11-16 2006-08-30 Smithkline Beecham Plc Novel composition based on thiazolidinedione and metformin and use
FR2812547B1 (fr) * 2000-08-04 2002-10-31 Lipha Composition pharmaceutique comprenant une association metformine et derive de thiazolidinedione et son utilisation pour la preparation de medicaments destines a traiter le diabete
US7964216B2 (en) 2001-01-12 2011-06-21 Sun Pharma Advanced Research Company Limited Spaced drug delivery system
ITFI20010126A1 (it) * 2001-07-09 2003-01-09 Molteni & C Composizioni farmaceutiche per uso orale,contenenti,in combinazione,metformina e gliclazide
MXPA04000180A (es) * 2001-07-10 2004-11-22 Kos Life Sciences Inc Formulacion de nucleo que comprende hidrocloruro de pioglitazona y una biguanida.
WO2003105809A1 (en) 2002-06-17 2003-12-24 Themis Laboratories Private Limited Multilayer tablets containing thiazolidinedione and biguanides and methods for producing them
UA80991C2 (en) 2002-10-07 2007-11-26 Solid preparation containing an insulin resistance improving drug and an active ingredient useful as a remedy for diabetes
NZ546337A (en) 2003-10-31 2009-03-31 Takeda Pharmaceutical Solid preparation comprising an insulin sensitizer such as pioglitazone hydrochloride, an insulin secretagogue such as glimepiride and a polyoxyethylene sorbitan fatty acid ester such as Polysorbate 80
MXPA05010977A (es) * 2005-10-12 2007-04-11 Abdala Leopoldo Espinosa Composiciones farmaceuticas que comprenden sustancias antidiabeticas combinadas para su uso en diabetes mellitus.
KR100812538B1 (ko) * 2006-10-23 2008-03-11 한올제약주식회사 약물 제어방출형 메트포르민-글리메피리드 복합제제
CN101417130B (zh) * 2007-10-22 2010-10-06 鲁南制药集团股份有限公司 一种治疗ⅱ型糖尿病及其并发症的药物组合物
JP7005050B2 (ja) 2017-10-20 2022-01-21 ノブメタファーマ カンパニー リミテッド 亜鉛塩、シクロ－ヒスプロおよび抗糖尿薬物を有効成分として含有する糖尿病の予防または治療用薬学的組成物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
JPS5697277A (en) * 1980-01-07 1981-08-05 Takeda Chem Ind Ltd Thiazolidine derivative
JPS6051189A (ja) * 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
US4582839A (en) * 1984-03-21 1986-04-15 Takeda Chemical Industries, Ltd. 2,4-thiazolidinediones
CN1003445B (zh) * 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物，其制备方法和用途
JPH06779B2 (ja) * 1985-06-10 1994-01-05 武田薬品工業株式会社 チアゾリジオン誘導体およびそれを含んでなる医薬組成物
US4812570A (en) * 1986-07-24 1989-03-14 Takeda Chemical Industries, Ltd. Method for producing thiazolidinedione derivatives
US4791125A (en) * 1987-12-02 1988-12-13 Pfizer Inc. Thiazolidinediones as hypoglycemic and anti-atherosclerosis agents
US5061717A (en) * 1988-03-08 1991-10-29 Pfizer Inc. Thiazolidinedione hypoglycemic agents
WO1989008651A1 (en) * 1988-03-08 1989-09-21 Pfizer Inc. Hypoglycemic thiazolidinedione derivatives
WO1991007107A1 (en) * 1989-11-13 1991-05-30 Pfizer Inc. Oxazolidinedione hypoglycemic agents
JPH04210683A (ja) * 1990-12-06 1992-07-31 Terumo Corp チアゾリジン−２，４−ジオン誘導体およびこれを含有する糖尿病合併症治療薬
DK0601001T3 (da) * 1991-08-26 1997-10-20 Upjohn Co Flydende næringsmiddelprodukt indeholdende 3-guanidinopropionsyre.
US5917052A (en) * 1994-09-28 1999-06-29 Shaman Pharmaceuticals, Inc. Hypoglycemic agent from cryptolepis
TWI238064B (en) * 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
EA003025B1 (ru) * 1997-06-18 2002-12-26 Смитклайн Бичам Плс Лечение диабета тиазолидиндионом и сульфонилмочевиной

Also Published As

Publication number Publication date
TW505516B (en) 2002-10-11
DZ2562A1 (fr) 2003-02-15
CN1264303A (zh) 2000-08-23
MA24607A1 (fr) 1999-04-01
EA200000139A1 (ru) 2000-06-26
CA2296653A1 (en) 1999-01-28
JP2001510159A (ja) 2001-07-31
HK1028550A1 (en) 2001-02-23
AR016349A1 (es) 2001-07-04
CY1105254T1 (el) 2010-03-03
HUP0003629A3 (en) 2003-04-28
IL134046A0 (en) 2001-04-30
ATE305790T1 (de) 2005-10-15
DK1001783T3 (da) 2006-02-06
UA70303C2 (uk) 2004-10-15
ID24211A (id) 2000-07-13
SA98190468B1 (ar) 2007-01-20
EA003021B1 (ru) 2002-12-26
PL338126A1 (en) 2000-09-25
SK592000A3 (en) 2000-09-12
KR100671918B1 (ko) 2007-01-22
EP1001783A1 (en) 2000-05-24
JP2005213273A (ja) 2005-08-11
NZ511608A (en) 2002-12-20
KR20010021947A (ko) 2001-03-15
GB9715295D0 (en) 1997-09-24
ES2251093T3 (es) 2006-04-16
NO20000228L (no) 2000-01-17
AP2000001733A0 (en) 2000-03-31
AP1352A (en) 2004-12-24
DE69831808T2 (de) 2006-07-06
TR200000134T2 (tr) 2000-09-21
NO20000228D0 (no) 2000-01-17
NO325727B1 (no) 2008-07-07
SK285484B6 (sk) 2007-02-01
CA2296653C (en) 2007-10-02
BG104135A (en) 2000-10-31
EP1001783B1 (en) 2005-10-05
BR9810445A (pt) 2000-09-05
DE69831808D1 (de) 2006-02-16
WO1999003477A1 (en) 1999-01-28
ZA986363B (en) 2000-01-17
BG64785B1 (bg) 2006-04-28
PL197844B1 (pl) 2008-05-30
SI1001783T1 (sl) 2006-02-28
PL198017B1 (pl) 2008-05-30
PE99599A1 (es) 1999-12-18
AU8448898A (en) 1999-02-10
NZ501164A (en) 2001-06-29
IN189275B (hu) 2003-01-25
UY25102A1 (es) 2000-12-29
CO4940420A1 (es) 2000-07-24
OA11279A (en) 2003-07-31
MY155219A (en) 2015-09-30

Similar Documents

Publication Publication Date Title
HUP0003629A2 (hu) Szinergista gyógyszerkészítmény diabetes kezelésére amely dioxo-tiazolidint, inzulin secretagogot és diguanidint tartalmaz
HUP0301194A2 (hu) Dipeptidil-peptidáz IV. inhibitorokból és más antidiabetikus szerekből álló kombinációs készítmények és alkalmazásuk diabetes mellitus kezelésére
RS49918B (sr) Upotreba glp-1, ili analoga za lečenje infarkta miokarda
NO20090846L (no) Kombinasjon og farmasoytisk blanding for behandling av diabetes samt anvendelse derav
ATE204178T1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
HUP0002373A2 (hu) Glükagon antagonisták/inverz agonisták és ezeket tartalmazó gyógyászati készítmények
DE58901401D1 (de) Pharmazeutische zubereitung zur behandlung des diabetes mellitus.
FI964332A (fi) Eräiden metaanibisfosfonihappojohdannaisten käyttö proteesin löystymisen ja proteesin vaelluksen estämiseen
BG103780A (en) Antitussive compositions
HUP0003260A2 (hu) Gyógyszerkészítmény diabetes kezelésére rosziglitazonnal és inzulinnal
HUP0003626A2 (hu) Gyógyszerkészítmény diabetes kezelésére dioxo-tiazolidinnel, inzulin secretagogummal és alfa-glükozidáz inhibitorral
ATE74271T1 (de) Ketonderivate als arzneimittel zur behandlung oder vorbeugung des entzugssyndromes.
KR950703353A (ko) 인슐린-의존적 진성 당뇨병을 예방 또는 치료하기 위한 인터루킨-10의 용도(Use of IL-10 to prevent or treat insulin-dependent diabetes mellitus)
KR970061249A (ko) 골다공증을 치료 또는 방지하기 위한 조성물
HUP0003634A2 (hu) Dioxo-tiazolidin-származékok és szulfonil-karbamid-származékok alkalmazása diabetes kezelésére szolgáló gyógyszerkészítmények előállítására
HUP9802897A2 (hu) Optikailag aktív piridil-4H-1,2,4-oxadiazin-származék, annak alkalmazása vaszkuláris betegségek kezelésére, valamint ilyen származékot hatóanyagként tartalmazó gyógyászati készítmény
RU2001118854A (ru) Оптически активное производное пиридил-4н-1,2,4-оксадиазина и его применение при лечении сосудистых заболеваний
CA2350396A1 (en) A composition useful to treat periodontal disease
DE69822810D1 (de) Somatostatin und somatostatin agoniste zur behandlung der insulinsunempfindlichkeit und syndrome x
WO2001070236A1 (en) Preventing and/or treating diabetes mellitus
HUP0104388A2 (hu) Béta-agonistákból és további antidiabetikus szerekből álló kombinációk
KR880004810A (ko) 소화성 궤양 치료제
RU99118510A (ru) Композиция для лечения или предупреждения рака простаты
ATE107504T1 (de) Arzneimittel zur behandlung von kryptosporidiose.
KR930017579A (ko) 신경 보호제

Legal Events

Date Code Title Description
FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished